AXOGEN INC (AXGN) Stock Price, Quote, News and Overview
NASDAQ:AXGN - Nasdaq - US05463X1063 - Common Stock - Currency: USD
AXGN Quote, Performance and Key Statistics
18
-0.5 (-2.7%)
The current stock price of AXGN is 18 USD. In the past month the price decreased by -3.74%. In the past year, price increased by 73.58%.
AXGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About AXGN
Company Profile
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 426 full-time employees. The company offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. Axoguard Nerve Connector is a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce nerve reconstruction while preventing soft tissue attachment. Axotouch Two-Point Discriminator is used to measure the innervation density of any surface area of the skin.
Company Info
AXOGEN INC
Suite 100, 13859 Progress Blvd.
Alachua FLORIDA 32615 US
CEO: Karen Zaderej
Employees: 427
Company Website: https://www.axogeninc.com/
Investor Relations: https://ir.axogeninc.com/
Phone: 13864626817
AXOGEN INC / AXGN FAQ
What is the stock price of AXOGEN INC today?
The current stock price of AXGN is 18 USD. The price decreased by -2.7% in the last trading session.
What is the ticker symbol for AXOGEN INC stock?
The exchange symbol of AXOGEN INC is AXGN and it is listed on the Nasdaq exchange.
On which exchange is AXGN stock listed?
AXGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AXOGEN INC stock?
13 analysts have analysed AXGN and the average price target is 19.23 USD. This implies a price increase of 6.86% is expected in the next year compared to the current price of 18. Check the AXOGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AXOGEN INC worth?
AXOGEN INC (AXGN) has a market capitalization of 792.18M USD. This makes AXGN a Small Cap stock.
How many employees does AXOGEN INC have?
AXOGEN INC (AXGN) currently has 427 employees.
What are the support and resistance levels for AXOGEN INC (AXGN) stock?
AXOGEN INC (AXGN) has a support level at 17.96 and a resistance level at 18.04. Check the full technical report for a detailed analysis of AXGN support and resistance levels.
Is AXOGEN INC (AXGN) expected to grow?
The Revenue of AXOGEN INC (AXGN) is expected to grow by 17.9% in the next year. Check the estimates tab for more information on the AXGN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AXOGEN INC (AXGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AXGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AXGN, evaluating the profitability, health, valuation and growth aspects
- AXOGEN INC (AXGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AXOGEN INC (AXGN) Sales and EPS estimates to see what analysts future expectations are.
- AXOGEN INC (AXGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AXOGEN INC (AXGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- AXOGEN INC (AXGN) Stock Chart to make your own analysis
- AXOGEN INC (AXGN) Latest news and press-releases to stay up to date.
Does AXOGEN INC (AXGN) stock pay dividends?
AXGN does not pay a dividend.
When does AXOGEN INC (AXGN) report earnings?
AXOGEN INC (AXGN) will report earnings on 2025-02-25, after the market close.
What is the Short Interest ratio of AXOGEN INC (AXGN) stock?
The outstanding short interest for AXOGEN INC (AXGN) is 4.51% of its float. Check the ownership tab for more information on the AXGN short interest.
AXGN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to AXGN. When comparing the yearly performance of all stocks, AXGN is one of the better performing stocks in the market, outperforming 94.76% of all stocks.
AXGN Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AXGN. AXGN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AXGN Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.45% | ||
| ROE | -14.39% | ||
| Debt/Equity | 0.48 |
AXGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to AXGN. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 144.39% and a revenue growth 17.9% for AXGN